June 12, 2017
Research mission is thriving
Research is a vital component of the tripartite mission of UI Health Care, and I am pleased to say that our research enterprise is thriving.
From the Iowa Neuroscience Institute moving forward with funding for new research efforts; to our selection as one of only three sites for an important vaccine trial; to our participation in a global research network to find collaborators and funding for research trials, the examples of our successful research enterprise are plentiful.
In addition, we continue to receive significant funding from the National Institutes of Health in some of our key research areas, such as diabetes, cystic fibrosis, cancer, and blinding eye diseases.
Whether studying human systems at the cellular level, translating laboratory discoveries into potential new therapies and treatments, or conducting clinical trials, our ultimate goal is the same—to improve and save lives by discovering new ways to prevent, diagnosis, and treat disease.
Finding new opportunities and funding for research and clinical trials is what inspired the UI Institute for Clinical and Translational Science (ICTS) to join TriNetX, a clinical research network that provides an interface between study sponsors (mostly biopharma and contract research organizations) to accelerate the clinical trial design and recruitment process. TriNetX also provides a tool for our researchers to do “prep to research” by exploring a de-identified version of our patient record.
The relationship with TriNetX has already proven worthwhile, with nine requests for clinical trials since joining the network in May 2017. For more information about TriNetX, visit icts.uiowa.edu/research/biomedical-informatics-core/trinetx or contact Ashlee Wilson in ICTS at firstname.lastname@example.org.
Our physicians, scientists, and staff have earned an outstanding reputation for UI Health Care’s research enterprise, and we are well-positioned to achieve new levels of discovery. I could not be more proud of all you achieve every day.
Next week, I will resume discussion of the 2017–2020 Strategic Plan with Goal 5: Strong Partnerships, with an aim to grow in Iowa and beyond by working with partners who share our values.
Research Enterprise By the Numbers
For Fiscal Year 2016:
- $229.4 million in external funding
- $117.1 million National Institutes of Health (NIH) funding
- NIH funding was up more than 13 percent from Fiscal Year 2015
- Approximately $19 million funding from philanthropy
- 233 total NIH grants
- 128 R01 grants
- 494 active patents
- 30 major research centers, institutes and programs
- 9 core research facilities
- U.S. News and World Report ranks UI Carver College of Medicine 35th in research among the nation’s 140 allopathic medical schools